IGC Pharma Inc (AMEX:IGC) price on Thursday, April 18, fall -18.82% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.48.
A look at the stock’s price movement, the close in the last trading session was $0.59. Turning to its 52-week performance, $0.91 and $0.25 were the 52-week high and 52-week low respectively. Overall, IGC moved 25.89% over the past month.
IGC Pharma Inc’s market cap currently stands at around $31.68 million.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that IGC is a 50% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 75% Buy category.
IGC’s current price about -3.48% and 22.38% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 50.50, while 7-day volatility ratio is 27.83% and 22.34% in the 30-day chart. Further, IGC Pharma Inc (IGC) has a beta value of 1.59, and an average true range (ATR) of 0.10.
If we refocus on IGC Pharma Inc (AMEX:IGC), historical trading data shows that trading volumes averaged 924.82K over the past 3 months. The company’s latest data on shares outstanding shows there are 66.54 million shares.
The 10.60% of IGC Pharma Inc’s shares are in the hands of company insiders while institutional holders own 3.71% of the company’s shares. Current price change has pushed the stock 69.98% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IGC stock continues to rise going into the next quarter.
